Clinical commissioning policy: allogeneic haematopoietic stem cell transplantation (Allo-HSCT) for adult transfusion dependent thalassaemia

Document first published:
Page updated:
Topic:
Publication type:

Allogeneic haematopoietic stem cell transplantation (Allo-HSCT) is recommended to be available as a routine commissioning treatment option for adults with transfusion dependent thalassaemia (TDT) within the criteria set out in this document.